Further enhances recently deployed PWeR(TM) platform WELLINGTON, Fla., Sept. 10
WELLINGTON, Fla., Sept. 10 /PRNewswire-FirstCall/ -- The Quantum Group,
Inc. (Amex: QGP) (www.QuantumMD.com), a Wellington, Florida based healthcare
organization, announced the filing of four new provisional patents to enhance
the proprietary PWeR(TM) platform developed by the Company and to drive
greater efficiencies within the healthcare industry.
The PWeR platform is an industry-wide, web-based healthcare information
system that has been recently deployed to serve the management needs of
healthcare professionals throughout Florida. These new patents support
technology that is intended to enhance the capabilities of this system
improving prescription accuracy; to offer real-time updates of patient
records; streamlining inventory management of supplies within a healthcare
provider's facility; and customizing the PWeR system for each user in order to
provide for a more efficient and productive experience. The Company is
positioning itself to lead as an innovator with its 13 provisional patents,
all designed to transform the healthcare industry at-large by offering
personalized processes and solutions for healthcare providers to positively
impact the quality of patient care.
Pete Martinez, Senior Vice President, Chief Technology and Innovations
Officer of the Quantum Group, stated, "These four new provisional patents
build upon our strategy to introduce the most innovative means of
communicating within the healthcare industry. Through our unique electronic
information system and technology, we are helping to revolutionize the
healthcare industry by making communications and document management more
efficient and cost-effective. While our patented technologies are going a
long way to serve the needs of healthcare professionals, in the end, we are
serving the needs of patients as our tools facilitate better care. Innovative
navigation tools, prescription checking, patient record management and
predictive modeling are all needed in healthcare. Our ability to deliver
these technologies demonstrates the strength of our platform and the
opportunities that lie ahead with our new patents."
Martinez continued, "The $2.3 trillion U.S. healthcare industry presents a
strong need for better quality and productivity. The lack of automation in
this industry is exemplified by the fact that most transactions are still
being conducted by either phone, paper or fax. We have created the
technological architecture to facilitate the interface between the healthcare
industry and 21st century business models, processes and technologies.
Fundamentally, we have looked at healthcare through the eyes of the consumer
(patient), provider (doctor) and scientist (researcher, educator) and created,
what we believe, to be the simplest, most effective and knowledge-rich
inventions for the healthcare industry."
About The Quantum Group, Inc.
The Quantum Group provides business process solutions, service chain
management, strategic consulting and leading edge technology innovations to
the healthcare industry.
Through our dynamic patient-centric architecture, we empower the
communication that is critical for the coordination of care and take aim at
the $600 billion inefficiency gap in the United States healthcare industry. We
are guided by a mission to develop efficiencies, improve the quality of
patient care and achieve cost reductions for the nation's largest and fastest
growing industry.
We have developed leading-edge technology with the creation and deployment
of a series of innovative patent-pending initiatives. Through approximately
2,000 healthcare providers and multiple insurance company relationships under
management, we are positioned to be a catalyst for change to the Florida
healthcare industry.
Certain statements contained in this news release, which are not based on
historical facts, are forward-looking statements as the term is defined in the
Private Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the respective
company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8 and 8-K
filings (and amendments thereto) that may cause actual results to materially
differ from projections. Forward-looking statements can be identified by the
use of words such as "expects," "plans," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates" and other words of similar
meaning. These statements are subject to risks and uncertainties that cannot
be predicted or quantified and, consequently, actual results may differ
materially from those expressed or implied by these forward-looking
statements. Such risk factors include, without limitation, the ability of the
Company to properly execute its business model, to raise substantial and
immediate additional capital to implement its business model, to attract and
retain executive, management and operational personnel, to continue growing
its patient base, to negotiate favorable current debt and future capital
raises, to negotiate favorable agreements with a diversified provider base and
to continue to supply the services needed by its HMO clients as well as
physician clients. The Company does not undertake any obligation to publicly
update any forward-looking statements. There can be no assurance that the
provisional patents discussed in this press release will be granted by the US
Patent and Trademark Office, or, if they are granted, they will not be
challenged by third parties, or if not that we will be able to effectively use
or commercialize such patents and/or we may not have the resources to deploy
such technology. As a result, investors should not place undue reliance on
these forward-looking statements.
FOR MORE INFORMATION, PLEASE CONTACT:
PR Financial Marketing
Jim Blackman: 713-256-0369
jim@prfmonline.com
or
The Quantum Group, Inc.
Danielle Amodio: 561.798.9800
damodio@quantummd.com
SOURCE The Quantum Group, Inc.
